Ceeto Capital Group’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Ceeto Capital Group’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-111	Closed	-$4.7K	–	131
2017 Q3	$4.7K	Buy	+111	New	+$4.29K	﹤0.01%	121

Other funds holding EVFM

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WAS

WESPAC Advisors SoCal Pasadena, California $560M AUM 37.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Ceeto Capital Group's EVFM Position: Q4 2017 in Review

Ceeto Capital Group sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2017, closing a stake of 111 shares — an estimated $4.7K sold.

Ceeto Capital Group first reported a position in EVFM in Q3 2017 and held it in 1 quarter. The position peaked at $4.7K in Q3 2017. 8 funds tracked by Wall St. Rank hold EVFM as of Q4 2017.

Ceeto Capital Group reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
Ceeto Capital Group sold 111 Evofem Biosciences, Inc. Common Stock shares in Q4 2017, an estimated $4.7K.
Ceeto Capital Group first reported a position in Evofem Biosciences, Inc. Common Stock in Q3 2017 and held it in 1 quarter.
Ceeto Capital Group's Evofem Biosciences, Inc. Common Stock position peaked at $4.7K in Q3 2017.
8 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2017.

Based on Ceeto Capital Group's 13F filing for Q4 2017, filed 12 Feb 2018.